1. Home
  2. BXBL vs DRTS Comparison

BXBL vs DRTS Comparison

Compare BXBL & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BOXABL Inc. Common stock

BXBL

BOXABL Inc. Common stock

N/A

Current Price

$4.37

Market Cap

1.4B

ML Signal

N/A

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$14.34

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXBL
DRTS
Founded
N/A
2015
Country
United States
Israel
Employees
N/A
N/A
Industry
Homebuilding
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
BXBL
DRTS
Price
$4.37
$14.34
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
172.9K
608.8K
Earning Date
N/A
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$699.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.18
$3.43
52 Week High
$5.42
$15.17

Technical Indicators

Market Signals
Indicator
BXBL
DRTS
Relative Strength Index (RSI) 49.16 54.28
Support Level $3.99 $13.65
Resistance Level $4.56 $14.93
Average True Range (ATR) 0.34 0.58
MACD 0.04 -0.08
Stochastic Oscillator 71.34 50.33

Price Performance

Historical Comparison
BXBL
DRTS

About BXBL BOXABL Inc. Common stock

BOXABL Inc is engaged in building construction using modern manufacturing processes to create residential and commercial buildings that can be completed in less time and at lower cost than traditional construction. The Company has developed a building system using manufacturing processes and existing technologies and processes developed by the automotive industry. Its products include the Casita and other building solutions using patented folding and shipping technology to transport buildings on existing roadways across large geographic areas.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: